Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

计划入组 60 人 · 首次发布于 2017 年 5 月 12 日

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

计划入组 58 人 · 首次发布于 2019 年 12 月 3 日

Lamivudine(LAM) Good Responder Study

计划入组 1 人 · 首次发布于 2010 年 5 月 24 日

PRT-01

LAM-30171

LAM-005

Astrana Health

United States

Laminar, Inc.

United States

LAMAR UNIVERSITY

United States

CUHK Researchers Uncover TREM2+ LAM Macrophage Mechanism Driving Liver Cancer Immunotherapy Resistance

Quince Therapeutics Reports Positive Phase 2a Results for LAM-001 in Pulmonary Hypertension

Hetao Zone Poised to Accelerate Hong Kong's Medical R&D Ambitions Through Cross-Border Clinical Trials